We are live on ! Find out more
Stanley-Laman Group

Stanley-Laman Group Portfolio holdings

AUM $915M Turnover 11.67%
1-Year Est. Return 50.26%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+50.26%
3 Year Est. Return
+113.93%
5 Year Est. Return
+106.15%
10 Year Est. Return
+368.2%
AUM
$915M
AUM Growth
-$69.1M
Cap. Flow
-$11.3M
Cap. Flow %
-1.24%
Top 10 Hldgs %
19.78%
Holding
317
New
19
Increased
50
Reduced
138
Closed
18
Avg Time Held
2.3 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$6.86M
2
GBCI icon
Glacier Bancorp
GBCI
+$5.86M
3
MNTN icon
MNTN
MNTN
+$4.47M
4
MOS icon
Mosaic
MOS
+$4.43M
5
FITB icon
Fifth Third Bancorp
FITB
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 36.13%
2 Miscellaneous 15.81%
3 Industrials 11.61%
4 Energy 8.7%
5 Healthcare 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IJR icon
176
iShares Core S&P Small-Cap ETF
IJR
$103B
$332K 0.04%
2,443
+31
+1% +$4.49K
2025 Q1
6 quarters
IBM icon
177
IBM
IBM
$218B
$330K 0.04%
1,500
– –
2024 Q2
9 quarters
VO icon
178
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$328K 0.04%
4,184
– –
2026 Q1
2 quarters
SRE icon
179
Sempra
SRE
$50.7B
$317K 0.03%
4,060
– –
2026 Q2
1 quarter
GOOG icon
180
Alphabet (Google) Class C
GOOG
$3.41T
$315K 0.03%
924
– –
2026 Q1
2 quarters
WMT icon
181
Walmart
WMT
$1.01T
$297K 0.03%
2,860
-10
-0.3% -$1.1K
2026 Q1
2 quarters
SPGI icon
182
S&P Global
SPGI
$131B
$295K 0.03%
747
-106
-12% -$44.9K
2024 Q3
8 quarters
NVS icon
183
Novartis
NVS
$301B
$286K 0.03%
2,006
+6
+0.3% +$910
2024 Q2
9 quarters
VRTX icon
184
Vertex Pharmaceuticals
VRTX
$135B
$280K 0.03%
536
-78
-13% -$39.9K
2025 Q4
3 quarters
MPC icon
185
Marathon Petroleum
MPC
$108B
$277K 0.03%
+700
New +$242K
2026 Q3
0 quarters
FIX icon
186
Comfort Systems
FIX
$38.5B
$276K 0.03%
167
– –
2026 Q2
1 quarter
QQQM icon
187
Invesco NASDAQ 100 ETF
QQQM
$104B
$271K 0.03%
891
– –
2026 Q1
2 quarters
VXUS icon
188
Vanguard Total International Stock ETF
VXUS
$157B
$271K 0.03%
3,189
+119
+4% +$10.2K
2025 Q4
3 quarters
SOLS icon
189
Solstice Advanced Materials
SOLS
$10B
$260K 0.03%
4,620
-90
-2% -$5.45K
2025 Q4
3 quarters
ELV icon
190
Elevance Health
ELV
$93.8B
$259K 0.03%
666
– –
2020 Q4
23 quarters
NOBL icon
191
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12.1B
$239K 0.03%
4,420
– –
2026 Q1
2 quarters
VFH icon
192
Vanguard Financials ETF
VFH
$13.4B
$239K 0.03%
1,834
– –
2026 Q1
2 quarters
ISRG icon
193
Intuitive Surgical
ISRG
$149B
$235K 0.03%
578
-2,454
-81% -$937K
2024 Q3
8 quarters
CME icon
194
CME Group
CME
$112B
$225K 0.02%
857
-237
-22% -$62.5K
2026 Q1
2 quarters
MFC icon
195
Manulife Financial
MFC
$72.4B
$222K 0.02%
5,204
– –
2026 Q2
1 quarter
SNPS icon
196
Synopsys
SNPS
$83.5B
$218K 0.02%
502
-147
-23% -$59.9K
2020 Q1
26 quarters
TLN icon
197
Talen Energy
TLN
$15.4B
$213K 0.02%
680
-191
-22% -$63.7K
2026 Q1
2 quarters
NFLX icon
198
Netflix
NFLX
$245B
$208K 0.02%
2,986
-1,630
-35% -$122K
2023 Q4
11 quarters
PSX icon
199
Phillips 66
PSX
$100B
$207K 0.02%
+810
New +$185K
2026 Q3
0 quarters
AFCG icon
200
Advanced Flower Capital
AFCG
$78.9M
$98.6K 0.01%
+27,400
New +$86.7K
2026 Q3
0 quarters

Similar funds

Stanley-Laman Group's Q3 2026 Portfolio in Review

As of Q3 2026, Stanley-Laman Group held 317 positions worth $915M, down 7% from $984M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Stanley-Laman Group's Q3 2026 filing shows 19 new, 50 increased, 138 reduced and 18 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 12,984 shares worth $6.54M. The largest sale was Lantheus, an estimated $7.54M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Miscellaneous and Industrials.

  • Stanley-Laman Group's largest Q3 2026 buy was Madrigal Pharmaceuticals: 12,984 shares worth $6.54M.
  • Stanley-Laman Group added most to Marten Transport in Q3 2026, an estimated $1.82M increase.
  • Stanley-Laman Group's biggest Q3 2026 reduction was AAR, cutting an estimated $2.12M.
  • Stanley-Laman Group fully exited Lantheus in Q3 2026, selling an estimated $7.54M.
  • Stanley-Laman Group's ten largest holdings make up 20% of its $915M portfolio in Q3 2026.
  • Stanley-Laman Group opened 19 new positions and closed 18 in Q3 2026.
  • Stanley-Laman Group's portfolio value fell 7% quarter-over-quarter to $915M.

Based on Stanley-Laman Group's 13F filing for Q3 2026, filed 20 Oct 2026.